<DOC>
	<DOCNO>NCT00046150</DOCNO>
	<brief_summary>The purpose study compare safety HMR 1964 insulin aspart use external pump respect catheter occlusion , GHb assessment , insulin dos , blood glucose parameter , hypoglycemic episode , unexplained hyperglycemia , adverse event , laboratory data , vital sign .</brief_summary>
	<brief_title>12 Week , Comparing Safety HMR1964 &amp; Insulin Aspart Used Continuous Subcutaneous Infusion Type 1 Diabetes .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>INCLUSION CRITERIA : Subjects meet follow criterion consider enrollment study : Men woman age 18 . Women either childbearing potential ( surgically sterile , postmenopausal 2 year ) pregnant agree use reliable contraceptive measure duration study . Reliable contraceptive measure include follow : systemic contraceptive ( oral , implant , injection ) , diaphragm intravaginal spermicide , cervical cap , intrauterine device , condom spermicide . Type 1 diabetes mellitus establish medical history ( purpose protocol : onset diabetes age 40 require continuous insulin therapy since diagnosis ) . At least 1 year continuous insulin treatment least 6 month continuous subcutaneous insulin infusion treatment immediately prior study entry . Use type external insulin pump ( MiniMed programmable pump , Disetronic pump type H Tron Plus V 100 D Tron ) least 3 month prior study entry . HbA1c &lt; 8.5 % measure visit 1 . Ability willingness perform blood glucose monitoring use sponsorprovided blood glucose meter subject diary home . Informed consent must obtain write subject enrollment study ( see Section 12.3 ) . EXCLUSION CRITERIA : Subjects present follow include study : Active proliferative diabetic retinopathy , define application focal panretinal photocoagulation vitrectomy , 6 month prior visit 1 , unstable ( rapidly progress ) retinopathy may require surgical treatment ( include laser photocoagulation ) study . Diabetes type 1 diabetes mellitus . History serious ketosis episode require hospitalization 3 previous month . History abscess infusion site previous 3 month . Pancreatectomised subject . Subjects undergone pancreas islet cell transplant . Likelihood require treatment study period drug permit study protocol ( see Section 6.2 ) . Treatment investigational drug last month visit 1 . History seizure disorder . History hypersensitivity insulin insulin analogues excipients HMR1964 insulin aspart formulation ( see Global Investigators Brochure [ 7 ] insulin aspart SPC [ 13 ] list excipients ) . Clinically relevant cardiovascular , hepatic , neurologic , endocrine , active cancer , major systemic disease make implementation protocol interpretation study result difficult would , opinion investigator , preclude safe participation subject protocol . History drug alcohol abuse . Impaired hepatic function , show limited ALT AST great twice normal upper limit measure visit 1 . Impaired renal function , show limited serum creatinine &gt; 177 micromol/L ( &gt; 2.0 mg/dL ) measure visit 1 . Pregnancy ( determined pregnancy blood test visit 1 ) breastfeeding . Night shift worker . Mental condition render subject unable understand nature , scope , possible consequence study . Subject unlikely comply protocol , e.g . inability unwillingness participate adequate training , uncooperative attitude , inability return followup visit , unlikelihood completing study . Employee sponsor sponsor representative . Subjects previously treat HMR1964 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>